Published Date: 18-Aug-2021
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Global Cerebrospinal Fluid Drainage Catheter Market, published by KBV research, The Global Cerebrospinal Fluid Drainage Catheter Market size is expected to reach $402.6 Million by 2027, rising at a market growth of 8.6% CAGR during the forecast period.
The ventricular drainage catheter segment obtained the highest revenue share in 2020 of the global Cerebrospinal Fluid Drainage Catheter Market. In addition, the segment would showcase a promising growth rate during the forecast period. The usage of ventricular drain catheters in order to remove excessive cerebrospinal fluid from the brain is fueled by the high occurrence rate of intraventricular hemorrhage and traumatic brain injuries, which could result in intracranial bleeding (hemorrhage).
In 2020, the traumatic brain injury segment obtained the highest revenue share of the global Cerebrospinal Fluid Drainage Catheter Market. Moreover, the segment would exhibit the maximum growth rate during the forecast period. The high occurrence rate of TBIs due to road accidents, falls or violence would accelerate the development of this segment during the forecast period.
The Asia Pacific would exhibit the maximum growth rate during the forecast period. Factors such as the existence of a big patient pool in developing countries, combined with growing healthcare expenses in this region are acting as catalysts for the growth of the regional market. Moreover, the growth of the regional market would also be fueled by the massive amount of investment in research and development activities by global market players in this region because of their low-cost framework.
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Medtronic PLC, Integra LifeSciences Holdings Corporation, Spiegelberg GmbH & Co. KG, Natus Medical Incorporated, B. Braun Melsungen AG, Johnson & Johnson, Moller Medical GmbH (Centrotec SE), Sophysa (Tokibo Co., Ltd.), Desu Medical, and Delta Surgical
Unique Offerings from KBV Research